ATE216385T1 - Substituierte 2-carboxyalkyl-3-(fluorphenyl)-8-(3-halopropen- -yl)-nortropane und ihre verwendung als kontrastmittel für neurodegenerative erkrankungen - Google Patents
Substituierte 2-carboxyalkyl-3-(fluorphenyl)-8-(3-halopropen- -yl)-nortropane und ihre verwendung als kontrastmittel für neurodegenerative erkrankungenInfo
- Publication number
- ATE216385T1 ATE216385T1 AT95900419T AT95900419T ATE216385T1 AT E216385 T1 ATE216385 T1 AT E216385T1 AT 95900419 T AT95900419 T AT 95900419T AT 95900419 T AT95900419 T AT 95900419T AT E216385 T1 ATE216385 T1 AT E216385T1
- Authority
- AT
- Austria
- Prior art keywords
- halopropen
- nortropane
- carboxyalkyl
- fluorophenyl
- substituted
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K51/0448—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil tropane or nortropane groups, e.g. cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/142,584 US5493026A (en) | 1993-10-25 | 1993-10-25 | Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders |
PCT/US1994/012225 WO1995011901A1 (en) | 1993-10-25 | 1994-10-24 | Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neurodegenerative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE216385T1 true ATE216385T1 (de) | 2002-05-15 |
Family
ID=22500439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95900419T ATE216385T1 (de) | 1993-10-25 | 1994-10-24 | Substituierte 2-carboxyalkyl-3-(fluorphenyl)-8-(3-halopropen- -yl)-nortropane und ihre verwendung als kontrastmittel für neurodegenerative erkrankungen |
Country Status (7)
Country | Link |
---|---|
US (2) | US5493026A (de) |
EP (2) | EP0734385B1 (de) |
AT (1) | ATE216385T1 (de) |
DE (1) | DE69430438T2 (de) |
DK (1) | DK0734385T3 (de) |
ES (1) | ES2172571T3 (de) |
WO (1) | WO1995011901A1 (de) |
Families Citing this family (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750089A (en) | 1996-01-11 | 1998-05-12 | Neuro Imaging Technologies, Llc | Halogenated neuroprobe for mapping monoamine reuptake sites |
US5493026A (en) * | 1993-10-25 | 1996-02-20 | Organix, Inc. | Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders |
AU6159796A (en) * | 1995-06-06 | 1996-12-24 | Research Biochemicals | Iodinated neuroprobes for mapping monoamine reuptake sites |
US6241963B1 (en) * | 1995-10-19 | 2001-06-05 | The Trustees Of The University Of Pennsylvania | Dopamine and serotonin transporter ligands and imaging agents |
US5948933A (en) | 1997-07-11 | 1999-09-07 | Organix, Inc. | Tropane analogs and methods for inhibition of monoamine transport |
US7081238B2 (en) * | 1995-11-03 | 2006-07-25 | The President And Fellows Of Harvard College | Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level |
US7105678B2 (en) | 1995-11-03 | 2006-09-12 | Organix, Inc. | Boat tropanes |
US6171576B1 (en) * | 1995-11-03 | 2001-01-09 | Organix Inc. | Dopamine transporter imaging agent |
FR2748475B1 (fr) * | 1996-05-10 | 1999-04-16 | Cis Bio Int | Derives du tropane utilisables en particulier pour la detection in vivo des transporteurs de la dopamine |
US7214686B2 (en) * | 1997-06-30 | 2007-05-08 | Targacept, Inc. | Pharmaceutical compositions and methods for effecting dopamine release |
US6001330A (en) * | 1997-09-12 | 1999-12-14 | Elmaleh; David R. | Diagnostic and therapeutic alkylenediamine compounds and process |
US6525386B1 (en) * | 1998-03-10 | 2003-02-25 | Masimo Corporation | Non-protruding optoelectronic lens |
AU4974700A (en) * | 1999-04-22 | 2000-11-10 | Emory University | Fluoroalkenyl nortropanes |
CA2285516C (en) * | 1999-05-12 | 2010-12-07 | President And Fellows Of Harvard College | Dopamine transporter imaging agents |
US7553478B2 (en) * | 1999-05-12 | 2009-06-30 | President And Fellows Of Harvard College | Methods for diagnosing and monitoring treatment ADHD by assessing the dopamine transporter level |
US20100143248A1 (en) * | 1999-06-28 | 2010-06-10 | President And Fellows Of Harvard College | Methods for diagnosing and monitoring treatment of adhd by assessing the dopamine transporter level |
US6440970B1 (en) | 2000-05-25 | 2002-08-27 | Targacept, Inc. | Pharmaceutical compositions and methods for use |
EP1289996B1 (de) | 2000-05-25 | 2005-04-06 | Targacept, Inc. | Heteroaryldiazabicycloalkane als liganden für den nikotinischen acetylcholin-rezeptor |
US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
DE20120708U1 (de) | 2001-10-09 | 2002-08-01 | Meltzer Peter C | Tropan-Analoga zur Inhibierung des Monoamin-Transports |
JP2005529156A (ja) * | 2002-03-28 | 2005-09-29 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | トロパン化合物 |
WO2003093412A2 (en) * | 2002-04-30 | 2003-11-13 | Emory University | Tumor imaging compounds |
PL1678172T3 (pl) * | 2003-10-15 | 2010-05-31 | Targacept Inc | Związki azabicykliczne do łagodzenia bólu oraz leczenia zaburzeń centralnego układu nerwowego |
US9017724B2 (en) | 2004-02-24 | 2015-04-28 | The General Hospital Corporation | Catalytic radiofluorination |
US8257680B1 (en) | 2004-02-24 | 2012-09-04 | The General Hospital Corporation | Catalytic radiofluorination |
CA2612186A1 (en) | 2005-06-23 | 2007-01-04 | Emory University | Imaging agents |
EP1893246A4 (de) * | 2005-06-23 | 2009-05-06 | Univ Emory | Stereoselektive synthese von aminosäureanaloga für tumorbildgebung |
ATE482959T1 (de) * | 2005-08-22 | 2010-10-15 | Targacept Inc | Heteroarylsubstituierte diazatricycloalkane, verfahren zu deren herstellung und deren anwendung |
EP2357174A1 (de) | 2006-05-09 | 2011-08-17 | AstraZeneca AB | Salzformen von (2S)-(4E)-N-Methyl-5-[(5-Isopropoxy)pyridin-3-yl]-4-Penten-2-Amin |
TWI389889B (zh) | 2006-05-09 | 2013-03-21 | Targacept Inc | (2s)-(4e)-n-甲基-5-〔3-(5-異丙氧基吡啶)基〕-4-戊烯-2-胺之新穎多晶型 |
TWI404532B (zh) * | 2006-11-02 | 2013-08-11 | Targacept Inc | 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺 |
TW200845977A (en) * | 2007-03-30 | 2008-12-01 | Targacept Inc | Sub-type selective azabicycloalkane derivatives |
SA08290475B1 (ar) | 2007-08-02 | 2013-06-22 | Targacept Inc | (2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه |
US20100221181A1 (en) * | 2007-09-26 | 2010-09-02 | Koninklijke Philips Electronics N.V. | Method of differentially diagnosing different types of dementia |
US8084018B2 (en) * | 2007-10-31 | 2011-12-27 | Alseres Pharmaceuticals, Inc. | Methods for imaging dopamine transporter level |
JP2011500857A (ja) * | 2007-10-31 | 2011-01-06 | アルセレス ファーマシューティカルズ, インコーポレイテッド | 標識ヨウ化トロパン処方物 |
CA2712141A1 (en) * | 2008-01-15 | 2009-07-23 | Targacept, Inc. | Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4] nonane and novel salt forms of the racemate and enantiomers |
US8246752B2 (en) | 2008-01-25 | 2012-08-21 | Clear Catheter Systems, Inc. | Methods and devices to clear obstructions from medical tubes |
CA2967254C (en) | 2008-02-29 | 2019-03-26 | Lantheus Medical Imaging, Inc. | Contrast agents for applications including imaging cancer |
KR20100122508A (ko) * | 2008-03-05 | 2010-11-22 | 타가셉트 인코포레이티드 | 디아자비시클로알칸의 니코틴 아세틸콜린 수용체 서브-타입 선택성 아미드 |
WO2009117728A2 (en) | 2008-03-21 | 2009-09-24 | The General Hospital Corporation | Compounds and compositions for the detection and treatment of alzheimer's disease and related disorders |
DE102008047314B4 (de) * | 2008-09-16 | 2012-08-30 | Johannes Gutenberg-Universität Mainz | Radioaktiv-markierte Cyclopropan-Derivate DAT-affiner Tropane |
US9145396B2 (en) | 2008-12-01 | 2015-09-29 | Targacept, Inc. | Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine |
WO2010065443A1 (en) | 2008-12-01 | 2010-06-10 | Targacept, Inc. | Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
CN102648202A (zh) | 2009-12-07 | 2012-08-22 | 塔加西普特公司 | 作为神经元烟碱乙酰胆碱受体配体的3,6-二氮杂双环[3.1.1]庚烷 |
JP6092628B2 (ja) | 2010-02-08 | 2017-03-08 | ランセウス メディカル イメージング, インコーポレイテッド | 造影剤およびその中間体を合成するための方法および装置 |
RU2582339C2 (ru) | 2010-05-27 | 2016-04-27 | Таргасепт, Инк. | Неконкурентные антагонисты никотиновых рецепторов |
WO2012125518A1 (en) | 2011-03-14 | 2012-09-20 | Targacept, Inc. | Salt forms of 3 - cyclopropylcarbonyl - 3, 6 - diazabicyclo [3.1.1] heptane |
TW201311698A (zh) | 2011-08-22 | 2013-03-16 | Targacept Inc | 作為神經元菸鹼乙醯膽鹼受體配位體之1,4-二氮雜雙環[3.2.2]壬烷 |
SG2014013767A (en) | 2011-09-09 | 2014-05-29 | Lantheus Medical Imaging Inc | Compositions, methods, and systems for the synthesis and use of imaging agents |
AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
US9724340B2 (en) | 2015-07-31 | 2017-08-08 | Attenua, Inc. | Antitussive compositions and methods |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3452029A (en) * | 1966-11-21 | 1969-06-24 | American Home Prod | 3-alpha-phenylbenzyloxy - 8 - substituted nortropanes and their substitutents |
US5496953A (en) * | 1990-08-09 | 1996-03-05 | Research Triangle Institute | Cocaine receptor binding ligands |
US5128118A (en) * | 1990-08-09 | 1992-07-07 | Research Triangle Institute | Cocaine receptor binding ligands |
US5310912A (en) * | 1992-02-25 | 1994-05-10 | Research Biochemicals Limited Partnership | Iodinated neuroprobe for mapping monoamine reuptake sites |
US5268480A (en) * | 1992-09-22 | 1993-12-07 | Mayo Foundation For Medical Education And Research | Cocaine analogs |
US5493026A (en) * | 1993-10-25 | 1996-02-20 | Organix, Inc. | Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders |
-
1993
- 1993-10-25 US US08/142,584 patent/US5493026A/en not_active Expired - Lifetime
-
1994
- 1994-10-24 DE DE69430438T patent/DE69430438T2/de not_active Expired - Lifetime
- 1994-10-24 DK DK95900419T patent/DK0734385T3/da active
- 1994-10-24 EP EP95900419A patent/EP0734385B1/de not_active Expired - Lifetime
- 1994-10-24 WO PCT/US1994/012225 patent/WO1995011901A1/en active IP Right Grant
- 1994-10-24 ES ES95900419T patent/ES2172571T3/es not_active Expired - Lifetime
- 1994-10-24 EP EP00123641A patent/EP1081147A2/de not_active Withdrawn
- 1994-10-24 AT AT95900419T patent/ATE216385T1/de active
-
1996
- 1996-02-20 US US08/605,332 patent/US5853696A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1081147A2 (de) | 2001-03-07 |
EP0734385B1 (de) | 2002-04-17 |
DK0734385T3 (da) | 2002-08-05 |
DE69430438T2 (de) | 2002-11-21 |
ES2172571T3 (es) | 2002-10-01 |
US5853696A (en) | 1998-12-29 |
WO1995011901A1 (en) | 1995-05-04 |
EP0734385A4 (de) | 1997-05-07 |
EP0734385A1 (de) | 1996-10-02 |
US5493026A (en) | 1996-02-20 |
DE69430438D1 (de) | 2002-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE216385T1 (de) | Substituierte 2-carboxyalkyl-3-(fluorphenyl)-8-(3-halopropen- -yl)-nortropane und ihre verwendung als kontrastmittel für neurodegenerative erkrankungen | |
DE69014074T2 (de) | Röntgenraster für medizinische röntgenaufnahmen und verfahren zu dessen herstellung und zu dessen verwendung. | |
AU2414092A (en) | Diagnostic method for alzheimer's disease | |
HK1007745A1 (en) | Dopamine receptor ligands and imaging agents | |
IL105216A0 (en) | Method and kit for the diagnosis of alzheimer's disease | |
CA2263961A1 (en) | Cocaine receptor binding ligands | |
FR2670669B1 (fr) | Instrument de correction chirurgicale de l'astigmatisme. | |
HK1102262A1 (en) | Stereoisomers of fatty acid analogs for diagnostic imaging | |
AU2002350950A1 (en) | Compounds for imaging alzheimer's disease | |
ES2115544A1 (es) | Sonda periodontal de medicion digital | |
FR2765591B1 (fr) | Procede de diagnostic de la maladie d'alzheimer | |
DE50202834D1 (de) | Verfahren zur Verbesserung der Auflösung einer nuklearmedizinischen Aufnahme | |
DE59408506D1 (de) | "Steroidzwischenprodukte und Verfahren zu ihrer Herstellung" | |
DE69414129T2 (de) | Biphenyl jodierte derivate und ihre verwendung als diagnostikum | |
PT86654A (pt) | Substituierte 3-phenyl-7h-thiazolo]3,2-b" ]1,2,4"triazin-7-one verfahren zu ihrer herstellung die sie enthaltenden arzneimittel und ihre verwendung sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte | |
GB9323826D0 (en) | Diagnosis of alzheimer's disease | |
DE69432561D1 (de) | Diagnose mentaler störungen | |
FR2622990B1 (fr) | Dispositif de stereolocalisation spatiale de sources d'activites cerebrales | |
AU718732C (en) | Diagnostic assay for Alzheimer's disease | |
AU3518897A (en) | Diagnostic assay for Alzheimer's disease | |
ES2148731T3 (es) | Agentes de contraste para rayos x destinados a la tomografia por ordenador y a la urografia. | |
ITMI911450A1 (it) | Endoapparecchio per il ripristino dell'articolazione coxofemorale | |
AU7467094A (en) | Method of diagnosing alzheimer's disease | |
GB9517266D0 (en) | Diagnosis of alzheimer's disease | |
Zimmerman et al. | A device for inverting the visual field of animals |